Last 12 months
Inside the activity.
7 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 11, 2021 Filed Jan 13, 2021 22:41 UTC |
Brophy GerardEVP, Biopharma Production
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 162,248 | $0.00 Strike: $23.21 | $0.00 |
DisclosureSEC source: 0001722482-21-000025 · wf-form4_161057768826138.xml · derivative · entry 5 Brophy Gerard · CIK 0001776107 · EVP, Biopharma Production 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,250 Underlying: Common Stock · 162,248 shares Expires 2028-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Reflects an initial grant of 540,830 stock options in which 40% vested at the time of IPO and the remaining 60% that vests in four equal installments beginning on July 30, 2019. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 22:41 UTC |
Brophy GerardEVP, Biopharma Production
|
SaleCommon Stock | 162,248 | $30.04 | $4,873,929.92 |
DisclosureSEC source: 0001722482-21-000025 · wf-form4_161057768826138.xml · nonDerivative · entry 4 Brophy Gerard · CIK 0001776107 · EVP, Biopharma Production 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,515 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $30.00 to $30.21, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth above Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 22:41 UTC |
Brophy GerardEVP, Biopharma Production
|
Exercise / conversionCommon Stock | 162,248 | $23.20 | $3,764,153.60 |
DisclosureSEC source: 0001722482-21-000025 · wf-form4_161057768826138.xml · nonDerivative · entry 3 Brophy Gerard · CIK 0001776107 · EVP, Biopharma Production 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 22:41 UTC |
Brophy GerardEVP, Biopharma Production
|
SaleCommon Stock | 216,332 | $30.08 | $6,507,266.56 |
DisclosureSEC source: 0001722482-21-000025 · wf-form4_161057768826138.xml · nonDerivative · entry 2 Brophy Gerard · CIK 0001776107 · EVP, Biopharma Production 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,515 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $30.00 to $30.33, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth above. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 22:41 UTC |
Brophy GerardEVP, Biopharma Production
|
Exercise / conversionCommon Stock | 216,332 | $23.20 | $5,018,902.40 |
DisclosureSEC source: 0001722482-21-000025 · wf-form4_161057768826138.xml · nonDerivative · entry 1 Brophy Gerard · CIK 0001776107 · EVP, Biopharma Production 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 394,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2021 Filed Jan 9, 2021 00:31 UTC |
Brophy GerardEVP, Biopharma Production
|
SaleCommon Stock | 11,509 | $27.24 | $313,505.16 |
DisclosureSEC source: 0001722482-21-000021 · wf-form4_161015226274868.xml · nonDerivative · entry 1 Brophy Gerard · CIK 0001776107 · EVP, Biopharma Production 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,515 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.07 to $27.54, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth above. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 02:06 UTC |
Brophy GerardEVP, Biopharma Production
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 59,418 | $0.00 Strike: $18.45 | $0.00 |
DisclosureSEC source: 0001722482-21-000010 · wf-form4_160998518340532.xml · derivative · entry 4 Brophy Gerard · CIK 0001776107 · EVP, Biopharma Production 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,835 Underlying: Common Stock · 59,418 shares Expires 2030-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Reflects an initial grant of 178,253 stock options that vest in three equal installments beginning on January 2, 2021. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 02:06 UTC |
Brophy GerardEVP, Biopharma Production
|
SaleCommon Stock | 59,418 | $27.84 | $1,654,197.12 |
DisclosureSEC source: 0001722482-21-000010 · wf-form4_160998518340532.xml · nonDerivative · entry 3 Brophy Gerard · CIK 0001776107 · EVP, Biopharma Production 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,024 F2 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.63 to $28.31, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth above. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 02:06 UTC |
Brophy GerardEVP, Biopharma Production
|
Exercise / conversionCommon Stock | 59,418 | $18.45 | $1,096,262.10 |
DisclosureSEC source: 0001722482-21-000010 · wf-form4_160998518340532.xml · nonDerivative · entry 2 Brophy Gerard · CIK 0001776107 · EVP, Biopharma Production 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,442 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2021 Filed Jan 7, 2021 02:00 UTC |
Szlosek Thomas AEVP & CFO
|
Tax withholdingCommon Stock | 8,135 | $28.15 | $229,000.25 |
DisclosureSEC source: 0001722482-21-000008 · wf-form4_160998480193205.xml · nonDerivative · entry 1 Szlosek Thomas A · CIK 0001293167 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,999 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| January 02, 2021 Filed Jan 7, 2021 02:06 UTC |
Brophy GerardEVP, Biopharma Production
|
Tax withholdingCommon Stock | 6,559 | $28.15 | $184,635.85 |
DisclosureSEC source: 0001722482-21-000010 · wf-form4_160998518340532.xml · nonDerivative · entry 1 Brophy Gerard · CIK 0001776107 · EVP, Biopharma Production 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,024 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| January 02, 2021 Filed Jan 7, 2021 01:56 UTC |
Vanderhaegen FredericEVP, Europe
|
Tax withholdingCommon Stock | 1,017 | $28.15 | $28,628.55 |
DisclosureSEC source: 0001722482-21-000006 · wf-form4_160998456508819.xml · nonDerivative · entry 1 Vanderhaegen Frederic · CIK 0001776162 · EVP, Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,414 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| January 02, 2021 Filed Jan 7, 2021 01:53 UTC |
Wondrasch MichaelEVP & CIO
|
Tax withholdingCommon Stock | 4,083 | $28.15 | $114,936.45 |
DisclosureSEC source: 0001722482-21-000004 · wf-form4_160998439432730.xml · nonDerivative · entry 1 Wondrasch Michael · CIK 0001776065 · EVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,974 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| December 31, 2020 Filed Jan 7, 2021 01:50 UTC |
Eck Steven WSVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 3,052 | $28.15 | $85,913.80 |
DisclosureSEC source: 0001722482-21-000002 · wf-form4_160998419649649.xml · nonDerivative · entry 1 Eck Steven W · CIK 0001748813 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,431 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| December 31, 2020 Filed Jan 7, 2021 22:24 UTC |
Henson MeghanEVP, Chief HR Officer
|
GrantStock Options (Right to Buy) · Derivative | 177,305 | $0.00 Strike: $28.15 | $0.00 |
DisclosureSEC source: 0001722482-21-000018 · wf-form4_161005826088889.xml · derivative · entry 2 Henson Meghan · CIK 0001839411 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,305 Underlying: Common Stock · 177,305 shares Expires 2030-12-31 F2 · derivative.exercise_date: Reflects a grant of stock options that vest in four equal annual installments beginning on December 31, 2021. Read SEC document |
| December 31, 2020 Filed Jan 7, 2021 22:24 UTC |
Henson MeghanEVP, Chief HR Officer
|
GrantCommon Stock | 17,762 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-21-000018 · wf-form4_161005826088889.xml · nonDerivative · entry 1 Henson Meghan · CIK 0001839411 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,762 F1 · kind: Reflects a grant of restricted stock units that vest in four equal annual installments beginning on December 31, 2021. Read SEC document |
| December 31, 2020 Filed Jan 7, 2021 22:21 UTC |
Lewis SheriEVP, Global Ops & Supply Chain
|
GrantStock Options (Right to Buy) · Derivative | 59,102 | $0.00 Strike: $28.15 | $0.00 |
DisclosureSEC source: 0001722482-21-000016 · wf-form4_161005809611899.xml · derivative · entry 2 Lewis Sheri · CIK 0001839410 · EVP, Global Ops & Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,102 Underlying: Common Stock · 59,102 shares Expires 2030-12-31 F2 · derivative.exercise_date: Reflects a grant of stock options that vest in four equal annual installments beginning on December 31, 2021. Read SEC document |
| December 31, 2020 Filed Jan 7, 2021 22:21 UTC |
Lewis SheriEVP, Global Ops & Supply Chain
|
GrantCommon Stock | 53,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-21-000016 · wf-form4_161005809611899.xml · nonDerivative · entry 1 Lewis Sheri · CIK 0001839410 · EVP, Global Ops & Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,286 F1 · kind: Reflects a grant of restricted stock units that vest in four equal annual installments beginning on December 31, 2021. Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 17:10 UTC |
Bramwell JamesEVP, Strategic Partners
|
SaleCommon Stock | 10,020 | $27.14 | $271,942.80 |
DisclosureSEC source: 0001722482-20-000180 · wf-form4_160876142139920.xml · nonDerivative · entry 1 Bramwell James · CIK 0001776099 · EVP, Strategic Partners 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,768 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.00 to $27.21, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth above. Read SEC document |
| December 11, 2020 Filed Dec 16, 2020 00:16 UTC |
Shaw ChristiDirector
|
SaleCommon Stock | 14,286 | $26.68 | $381,150.48 |
DisclosureSEC source: 0001722482-20-000176 · wf-form4_160807776567001.xml · nonDerivative · entry 1 Shaw Christi · CIK 0001702473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,319 F1 · kind: The sale reported herein reflects the transfer of shares received upon the vesting of restricted stock units. The shares transferred were subject to a lock-up agreement entered into by the Reporting Person on November 5, 2020, in connection with a secondary offering. This transaction was permitted pursuant to an exception in the lock-up agreement for parties that did not participate in such secondary offering. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $26.60 to $26.73, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth above. Read SEC document |
| December 11, 2020 Filed Dec 16, 2020 00:19 UTC |
Stubblefield MichaelDirector · President and CEO
|
GiftCommon Stock | 400,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-20-000178 · wf-form4_160807796110426.xml · nonDerivative · entry 2 Stubblefield Michael · CIK 0001776153 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 400,000 F1 · kind: Reflects a gift of shares by the Reporting Person to a trust for the benefit of the Reporting Person's family, of which the spouse of the Reporting Person is the trustee. F2 · ownership.nature: Reflects securities held by a trust for the benefit of the Reporting Person's family, of which the spouse of the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of the securities held by the trust, except to the extent of his pecuniary interest therein. Read SEC document |
| December 11, 2020 Filed Dec 16, 2020 00:19 UTC |
Stubblefield MichaelDirector · President and CEO
|
GiftCommon Stock | 400,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-20-000178 · wf-form4_160807796110426.xml · nonDerivative · entry 1 Stubblefield Michael · CIK 0001776153 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,447,265 F1 · kind: Reflects a gift of shares by the Reporting Person to a trust for the benefit of the Reporting Person's family, of which the spouse of the Reporting Person is the trustee. Read SEC document |
| December 11, 2020 Filed Feb 16, 2021 18:17 UTC |
GUPTA RAJIVDirector
|
GiftCommon Stock | 316,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-21-000043 · wf-form5_161351741592443.xml · nonDerivative · entry 1 GUPTA RAJIV · CIK 0001068731 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,440,716 Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 00:09 UTC |
Stubblefield MichaelDirector · President and CEO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 201,369 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001722482-20-000174 · wf-form4_160747256680082.xml · derivative · entry 6 Stubblefield Michael · CIK 0001776153 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 201,369 shares Expires 2024-05-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan. F5 · derivative.exercise_date: These options are fully vested. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 00:09 UTC |
Stubblefield MichaelDirector · President and CEO
|
SaleCommon Stock | 98,452 | $27.45 | $2,702,507.40 |
DisclosureSEC source: 0001722482-20-000174 · wf-form4_160747256680082.xml · nonDerivative · entry 4 Stubblefield Michael · CIK 0001776153 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,847,265 F2 · kind: Reflects shares sold to cover the Reporting Person's exercise price and tax liability in connection with the exercise of stock options. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.24 to $27.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 00:09 UTC |
Stubblefield MichaelDirector · President and CEO
|
Exercise / conversionCommon Stock | 210,369 | $1.60 | $336,590.40 |
DisclosureSEC source: 0001722482-20-000174 · wf-form4_160747256680082.xml · nonDerivative · entry 3 Stubblefield Michael · CIK 0001776153 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,945,717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| December 04, 2020 Filed Dec 9, 2020 00:09 UTC |
Stubblefield MichaelDirector · President and CEO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 880,601 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001722482-20-000174 · wf-form4_160747256680082.xml · derivative · entry 5 Stubblefield Michael · CIK 0001776153 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,369 Underlying: Common Stock · 880,601 shares Expires 2024-05-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan. F5 · derivative.exercise_date: These options are fully vested. Read SEC document |
| December 04, 2020 Filed Dec 9, 2020 00:09 UTC |
Stubblefield MichaelDirector · President and CEO
|
SaleCommon Stock | 412,188 | $27.08 | $11,162,051.04 |
DisclosureSEC source: 0001722482-20-000174 · wf-form4_160747256680082.xml · nonDerivative · entry 2 Stubblefield Michael · CIK 0001776153 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,735,348 F2 · kind: Reflects shares sold to cover the Reporting Person's exercise price and tax liability in connection with the exercise of stock options. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $26.77 to $27.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| December 04, 2020 Filed Dec 9, 2020 00:09 UTC |
Stubblefield MichaelDirector · President and CEO
|
Exercise / conversionCommon Stock | 880,601 | $1.60 | $1,408,961.60 |
DisclosureSEC source: 0001722482-20-000174 · wf-form4_160747256680082.xml · nonDerivative · entry 1 Stubblefield Michael · CIK 0001776153 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,147,536 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| November 10, 2020 Filed Nov 10, 2020 21:24 UTC |
New Mountain Investments III, LLC10% owner
New Mountain Partners III LP10% owner
New Mountain Capital, L.L.C.10% owner
New Mountain Capital Group, L.P.10% owner
NM Holdings GP, L.L.C.10% owner
KLINSKY STEVEN B10% owner
|
SaleCommon Stock | 36,016,093 | $24.81 | $893,490,836.75 |
DisclosureSEC source: 0000899243-20-030762 · doc4.xml · nonDerivative · entry 1 New Mountain Investments III, LLC · CIK 0001515175 · 10% owner New Mountain Partners III LP · CIK 0001403510 · 10% owner New Mountain Capital, L.L.C. · CIK 0001407718 · 10% owner New Mountain Capital Group, L.P. · CIK 0001777024 · 10% owner NM Holdings GP, L.L.C. · CIK 0001776766 · 10% owner KLINSKY STEVEN B · CIK 0001018327 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 28,000,000 F1 · price: This amount represents the $25.25 public offering price per share of common stock of the Issuer ("Common Stock"), less the underwriting discount of $0.441875 per share of Common Stock. F2 · ownership.nature: These securities are directly held by New Mountain Partners III, L.P. The general partner of New Mountain Partners III, L.P. is New Mountain Investments III, L.L.C. and the manager of New Mountain Partners III, L.P. is New Mountain Capital, L.L.C. Steven B. Klinsky is the managing member of New Mountain Investments III, L.L.C. The managing member of New Mountain Capital, L.L.C. is New Mountain Capital Group, L.P. The general partner of New Mountain Capital Group, L.P. is NM Holdings GP, L.L.C. Steven B. Klinsky is the managing member of NM Holdings GP, L.L.C. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein. Read SEC document |
| October 05, 2020 Filed Oct 8, 2020 00:23 UTC |
Ohri DevashishEVP, IMEA
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001722482-20-000159 · wf-form4_160211658325910.xml · derivative · entry 9 Ohri Devashish · CIK 0001776125 · EVP, IMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,160 Underlying: Common Stock · 50,000 shares Expires 2025-03-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options are fully vested. Read SEC document |
| October 05, 2020 Filed Oct 8, 2020 00:23 UTC |
Ohri DevashishEVP, IMEA
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001722482-20-000159 · wf-form4_160211658325910.xml · derivative · entry 8 Ohri Devashish · CIK 0001776125 · EVP, IMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,160 Underlying: Common Stock · 35,000 shares Expires 2025-03-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options are fully vested. Read SEC document |
| October 05, 2020 Filed Oct 8, 2020 00:23 UTC |
Ohri DevashishEVP, IMEA
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 18,440 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001722482-20-000159 · wf-form4_160211658325910.xml · derivative · entry 7 Ohri Devashish · CIK 0001776125 · EVP, IMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,440 shares Expires 2024-09-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options are fully vested. Read SEC document |
| October 05, 2020 Filed Oct 8, 2020 00:23 UTC |
Ohri DevashishEVP, IMEA
|
SaleCommon Stock | 50,000 | $23.34 | $1,167,000.00 |
DisclosureSEC source: 0001722482-20-000159 · wf-form4_160211658325910.xml · nonDerivative · entry 6 Ohri Devashish · CIK 0001776125 · EVP, IMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,671 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.25 to $23.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| October 05, 2020 Filed Oct 8, 2020 00:23 UTC |
Ohri DevashishEVP, IMEA
|
Exercise / conversionCommon Stock | 50,000 | $1.60 | $80,000.00 |
DisclosureSEC source: 0001722482-20-000159 · wf-form4_160211658325910.xml · nonDerivative · entry 5 Ohri Devashish · CIK 0001776125 · EVP, IMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,671 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 05, 2020 Filed Oct 8, 2020 00:23 UTC |
Ohri DevashishEVP, IMEA
|
SaleCommon Stock | 35,000 | $23.47 | $821,450.00 |
DisclosureSEC source: 0001722482-20-000159 · wf-form4_160211658325910.xml · nonDerivative · entry 4 Ohri Devashish · CIK 0001776125 · EVP, IMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,671 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.26 to $23.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above Read SEC document |
| October 05, 2020 Filed Oct 8, 2020 00:23 UTC |
Ohri DevashishEVP, IMEA
|
Exercise / conversionCommon Stock | 35,000 | $1.60 | $56,000.00 |
DisclosureSEC source: 0001722482-20-000159 · wf-form4_160211658325910.xml · nonDerivative · entry 3 Ohri Devashish · CIK 0001776125 · EVP, IMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,671 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 05, 2020 Filed Oct 8, 2020 00:23 UTC |
Ohri DevashishEVP, IMEA
|
SaleCommon Stock | 18,440 | $23.53 | $433,893.20 |
DisclosureSEC source: 0001722482-20-000159 · wf-form4_160211658325910.xml · nonDerivative · entry 2 Ohri Devashish · CIK 0001776125 · EVP, IMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,671 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.26 to $23.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| October 05, 2020 Filed Oct 8, 2020 00:23 UTC |
Ohri DevashishEVP, IMEA
|
Exercise / conversionCommon Stock | 18,440 | $1.60 | $29,504.00 |
DisclosureSEC source: 0001722482-20-000159 · wf-form4_160211658325910.xml · nonDerivative · entry 1 Ohri Devashish · CIK 0001776125 · EVP, IMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,111 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2020 Filed Sep 17, 2020 20:39 UTC |
Ohri DevashishEVP, IMEA
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001722482-20-000156 · wf-form4_160037516920176.xml · derivative · entry 3 Ohri Devashish · CIK 0001776125 · EVP, IMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,440 Underlying: Common Stock · 35,000 shares Expires 2024-09-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options are fully vested. Read SEC document |
| September 16, 2020 Filed Sep 17, 2020 20:39 UTC |
Ohri DevashishEVP, IMEA
|
SaleCommon Stock | 35,000 | $23.02 | $805,700.00 |
DisclosureSEC source: 0001722482-20-000156 · wf-form4_160037516920176.xml · nonDerivative · entry 2 Ohri Devashish · CIK 0001776125 · EVP, IMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,671 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.00 to $23.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| September 16, 2020 Filed Sep 17, 2020 20:39 UTC |
Ohri DevashishEVP, IMEA
|
Exercise / conversionCommon Stock | 35,000 | $1.60 | $56,000.00 |
DisclosureSEC source: 0001722482-20-000156 · wf-form4_160037516920176.xml · nonDerivative · entry 1 Ohri Devashish · CIK 0001776125 · EVP, IMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,671 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2020 Filed Sep 9, 2020 20:43 UTC |
Miller JustinEVP & General Counsel
|
SaleCommon Stock | 22,887 | $21.17 | $484,517.79 |
DisclosureSEC source: 0001722482-20-000154 · wf-form4_159968421885214.xml · nonDerivative · entry 1 Miller Justin · CIK 0001776122 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,507 F1 · kind: The sale reported herein reflects the transfer of shares received upon the vesting of restricted stock units. This transaction was permitted pursuant to a lock-up agreement entered into by the Reporting Person on August 19, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $21.04 to $21.25, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth above. Read SEC document |
| August 21, 2020 Filed Aug 25, 2020 17:08 UTC |
New Mountain Investments III, LLC10% owner
New Mountain Partners III LP10% owner
New Mountain Capital, L.L.C.10% owner
New Mountain Capital Group, L.P.10% owner
NM Holdings GP, L.L.C.10% owner
KLINSKY STEVEN B10% owner
|
SaleCommon Stock | 25,575,472 | $19.51 | $498,887,944.57 |
DisclosureSEC source: 0000899243-20-023373 · doc4.xml · nonDerivative · entry 1 New Mountain Investments III, LLC · CIK 0001515175 · 10% owner New Mountain Partners III LP · CIK 0001403510 · 10% owner New Mountain Capital, L.L.C. · CIK 0001407718 · 10% owner New Mountain Capital Group, L.P. · CIK 0001777024 · 10% owner NM Holdings GP, L.L.C. · CIK 0001776766 · 10% owner KLINSKY STEVEN B · CIK 0001018327 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 64,016,093 F1 · price: This amount represents the $19.5065 sale price per share of the Common Stock of the Issuer received by the Reporting Persons in connection with a secondary block trade which closed on August 21, 2020. F2 · ownership.nature: These securities are directly held by New Mountain Partners III, L.P. The general partner of New Mountain Partners III, L.P. is New Mountain Investments III, L.L.C. and the manager of New Mountain Partners III, L.P. is New Mountain Capital, L.L.C. Steven B. Klinsky is the managing member of New Mountain Investments III, L.L.C. The managing member of New Mountain Capital, L.L.C. is New Mountain Capital Group, L.P. The general partner of New Mountain Capital Group, L.P. is NM Holdings GP, L.L.C. Steven B. Klinsky is the managing member of NM Holdings GP, L.L.C. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein. Read SEC document |
| August 21, 2020 Filed Aug 26, 2020 00:46 UTC |
Natauri JoDirector
|
SaleCommon Stock, par value $0.01 per share | 15,397,005 | $19.51 | $300,341,678.03 |
DisclosureSEC source: 0000769993-20-000332 · ownershipdoc08252020034653.xml · nonDerivative · entry 1 Natauri Jo · CIK 0001776123 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 43,483,708 F2 · shares: Pursuant to an underwriting agreement, dated August 19, 2020, and in connection with the registered public offering of shares of common stock, par value $0.01 per share, of the Issuer ("Common Stock") pursuant to the prospectus, dated as of August 19, 2020 and filed with the U.S. Securities and Exchange Commission on August 21, 2020 pursuant to Rule 424(b)(7) under the Securities Act, which offering was consummated on August 21, 2020 (the "Offering"), Broad Street Principal Investments, L.L.C. ("BSPI") sold 15,397,005 shares of Common Stock. Goldman Sachs was one of the underwriters in the Offering. F3 · balance_after: As of August 21, 2020, after giving effect to the sale made in connection with the Offering, Goldman Sachs and GS Group may be deemed to beneficially own indirectly 43,481,933 shares of Common Stock by reason of direct beneficial ownership of such shares by StoneBridge 2017, L.P., StoneBridge 2017 Offshore, L.P., VWR Partners, L.P., StoneBridge 2018, L.P., StoneBridge 2018 Offshore, L.P. (together, the "GS Funds") and BSPI. Bridge Street Opportunity Advisors, L.L.C. ("Bridge Street) is the sole general partner of each of the GS Funds and an indirect wholly-owned subsidiary of GS Group. Goldman Sachs is the manager of BSPI and Bridge Street, and the investment manager of each of the GS Funds. In addition, Goldman Sachs and GS Group may be deemed to beneficially own 1,775 shares of Common Stock from exempt transactions. F1 · ownership.nature: The Reporting Person is a managing director of Goldman Sachs & Co. LLC ("Goldman Sachs"). Goldman Sachs is a direct subsidiary of The Goldman Sachs Group, Inc. ("GS Group"). The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Exchange Act, or for any other purpose. F2 · ownership.nature: Pursuant to an underwriting agreement, dated August 19, 2020, and in connection with the registered public offering of shares of common stock, par value $0.01 per share, of the Issuer ("Common Stock") pursuant to the prospectus, dated as of August 19, 2020 and filed with the U.S. Securities and Exchange Commission on August 21, 2020 pursuant to Rule 424(b)(7) under the Securities Act, which offering was consummated on August 21, 2020 (the "Offering"), Broad Street Principal Investments, L.L.C. ("BSPI") sold 15,397,005 shares of Common Stock. Goldman Sachs was one of the underwriters in the Offering. F3 · ownership.nature: As of August 21, 2020, after giving effect to the sale made in connection with the Offering, Goldman Sachs and GS Group may be deemed to beneficially own indirectly 43,481,933 shares of Common Stock by reason of direct beneficial ownership of such shares by StoneBridge 2017, L.P., StoneBridge 2017 Offshore, L.P., VWR Partners, L.P., StoneBridge 2018, L.P., StoneBridge 2018 Offshore, L.P. (together, the "GS Funds") and BSPI. Bridge Street Opportunity Advisors, L.L.C. ("Bridge Street) is the sole general partner of each of the GS Funds and an indirect wholly-owned subsidiary of GS Group. Goldman Sachs is the manager of BSPI and Bridge Street, and the investment manager of each of the GS Funds. In addition, Goldman Sachs and GS Group may be deemed to beneficially own 1,775 shares of Common Stock from exempt transactions. F4 · ownership.nature: The Reporting Person is currently analyzing additional trading activity in Avantor, Inc.'s equity securities and expects to file another Form 4 as promptly as reasonably practicable once that analysis is complete. Read SEC document |
| August 21, 2020 Filed Aug 26, 2020 00:40 UTC |
GOLDMAN SACHS & CO. LLC10% owner
StoneBridge 2017, L.P.10% owner
StoneBridge 2017 Offshore, L.P.10% owner
VWR Partners, L.P.10% owner
GOLDMAN SACHS GROUP INC10% owner
StoneBridge 2018 Offshore, L.P.10% owner
StoneBridge 2018, L.P.10% owner
|
SaleCommon Stock, par value $0.01 per share | 15,397,005 | $19.51 | $300,341,678.03 |
DisclosureSEC source: 0000769993-20-000331 · ownershipdoc08252020034653.xml · nonDerivative · entry 1 GOLDMAN SACHS & CO. LLC · CIK 0000769993 · 10% owner StoneBridge 2017, L.P. · CIK 0001698772 · 10% owner StoneBridge 2017 Offshore, L.P. · CIK 0001698770 · 10% owner VWR Partners, L.P. · CIK 0001708241 · 10% owner Broad Street Principal Investments, L.L.C. · CIK 0001575993 · 10% owner Bridge Street Opportunity Advisors, L.L.C. · CIK 0001615636 · 10% owner GOLDMAN SACHS GROUP INC · CIK 0000886982 · 10% owner StoneBridge 2018 Offshore, L.P. · CIK 0001729503 · 10% owner StoneBridge 2018, L.P. · CIK 0001729502 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 43,483,708 F2 · shares: Pursuant to an underwriting agreement, dated August 19, 2020, and in connection with the registered public offering of shares of common stock, par value $0.01 per share, of the Issuer ("Common Stock") pursuant to the prospectus, dated as of August 19, 2020 and filed with the U.S. Securities and Exchange Commission on August 21, 2020 pursuant to Rule 424(b)(7) under the Securities Act, which offering was consummated on August 21, 2020 (the "Offering"), BSPI sold 15,397,005 shares of Common Stock. Goldman Sachs was one of the underwriters in the Offering. F3 · balance_after: As of August 21, 2020, after giving effect to the sale made in connection with the Offering, (i) BSPI owns directly 10,507,085 shares of Common Stock, (ii) StoneBridge 2017 owns directly 683,221 shares of Common Stock, (iii) StoneBridge 2017 Offshore owns directly 315,779 shares of Common Stock, (iv) VWR owns directly 29,007,209 shares of Common Stock, (v) StoneBridge 2018 owns directly 2,089,674 shares of Common Stock and (vi) StoneBridge 2018 Offshore owns directly 878,965 shares of Common Stock. F4 · balance_after: Bridge Street is the sole general partner of each of the GS Funds and may be deemed to beneficially own indirectly 32,974,848 shares of Common Stock by reason of direct beneficial ownership of such shares by the GS Funds. F5 · balance_after: Goldman Sachs and GS Group may be deemed to beneficially own indirectly 43,481,933 shares of Common Stock by reason of direct beneficial ownership of such shares by the GS Funds and BSPI. Bridge Street, the sole general partner of each of the GS Funds, is an indirect wholly-owned subsidiary of GS Group. Goldman Sachs is the manager of BSPI and Bridge Street, and the investment manager of each of the GS Funds. Goldman Sachs is a direct subsidiary of GS Group. In addition, Goldman Sachs and GS Group may be deemed to beneficially own 1,775 shares of Common Stock from exempt transactions. F1 · ownership.nature: This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group"), Goldman Sachs & Co. LLC ("Goldman Sachs"), Broad Street Principal Investments, L.L.C. ("BSPI"), StoneBridge 2017, L.P. ("StoneBridge 2017"), StoneBridge 2017 Offshore, L.P. ("StoneBridge 2017 Offshore"), VWR Partners, L.P. ("VWR"), StoneBridge 2018, L.P. ("StoneBridge 2018"), StoneBridge 2018 Offshore, L.P. ("StoneBridge 2018 Offshore" and, together with StoneBridge 2017, StoneBridge 2017 Offshore, VWR and StoneBridge 2018, the "GS Funds") and Bridge Street Opportunity Advisors, L.L.C. ("Bridge Street"). GS Group, Goldman Sachs, BSPI, the GS Funds and Bridge Street are defined collectively as the "Reporting Persons". F2 · ownership.nature: Pursuant to an underwriting agreement, dated August 19, 2020, and in connection with the registered public offering of shares of common stock, par value $0.01 per share, of the Issuer ("Common Stock") pursuant to the prospectus, dated as of August 19, 2020 and filed with the U.S. Securities and Exchange Commission on August 21, 2020 pursuant to Rule 424(b)(7) under the Securities Act, which offering was consummated on August 21, 2020 (the "Offering"), BSPI sold 15,397,005 shares of Common Stock. Goldman Sachs was one of the underwriters in the Offering. F3 · ownership.nature: As of August 21, 2020, after giving effect to the sale made in connection with the Offering, (i) BSPI owns directly 10,507,085 shares of Common Stock, (ii) StoneBridge 2017 owns directly 683,221 shares of Common Stock, (iii) StoneBridge 2017 Offshore owns directly 315,779 shares of Common Stock, (iv) VWR owns directly 29,007,209 shares of Common Stock, (v) StoneBridge 2018 owns directly 2,089,674 shares of Common Stock and (vi) StoneBridge 2018 Offshore owns directly 878,965 shares of Common Stock. F4 · ownership.nature: Bridge Street is the sole general partner of each of the GS Funds and may be deemed to beneficially own indirectly 32,974,848 shares of Common Stock by reason of direct beneficial ownership of such shares by the GS Funds. F5 · ownership.nature: Goldman Sachs and GS Group may be deemed to beneficially own indirectly 43,481,933 shares of Common Stock by reason of direct beneficial ownership of such shares by the GS Funds and BSPI. Bridge Street, the sole general partner of each of the GS Funds, is an indirect wholly-owned subsidiary of GS Group. Goldman Sachs is the manager of BSPI and Bridge Street, and the investment manager of each of the GS Funds. Goldman Sachs is a direct subsidiary of GS Group. In addition, Goldman Sachs and GS Group may be deemed to beneficially own 1,775 shares of Common Stock from exempt transactions. F6 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any such Reporting Person is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Exchange Act, or for any other purpose. F7 · ownership.nature: The Reporting Persons are currently analyzing additional trading activity in Avantor, Inc.'s equity securities and expect to file another Form 4 as promptly as reasonably practicable once that analysis is complete. Read SEC document |
| August 19, 2020 Filed Aug 19, 2020 14:06 UTC |
GUPTA RAJIVDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 430,325 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001722482-20-000152 · wf-form4_159786036300368.xml · derivative · entry 5 GUPTA RAJIV · CIK 0001068731 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 430,325 shares Expires 2021-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options are fully vested. Read SEC document |
| August 19, 2020 Filed Aug 19, 2020 14:06 UTC |
GUPTA RAJIVDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 717,645 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001722482-20-000152 · wf-form4_159786036300368.xml · derivative · entry 4 GUPTA RAJIV · CIK 0001068731 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 717,645 shares Expires 2020-11-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options are fully vested. Read SEC document |
| August 19, 2020 Filed Aug 19, 2020 14:06 UTC |
GUPTA RAJIVDirector
|
GiftCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-20-000152 · wf-form4_159786036300368.xml · nonDerivative · entry 2 GUPTA RAJIV · CIK 0001068731 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,756,716 F1 · kind: Reflects a gift to his adult daughters. Read SEC document |
| August 19, 2020 Filed Aug 19, 2020 14:06 UTC |
GUPTA RAJIVDirector
|
Exercise / conversionCommon Stock | 1,147,970 | $1.60 | $1,836,752.00 |
DisclosureSEC source: 0001722482-20-000152 · wf-form4_159786036300368.xml · nonDerivative · entry 1 GUPTA RAJIV · CIK 0001068731 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,856,716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.